CryoGen Anticipates Q2 2000 IDE Filing For Cardiac Cryoablation Device
This article was originally published in The Gray Sheet
Executive Summary
CryoGen's transcatheter cryoablation device for the treatment of certain heart arrhythmias could enable physicians to treat ventricular tachycardia (VT), a condition not effectively addressed by radiofrequency (RF) ablation devices, the company claims.